Chemed EBITDA 2010-2024 | CHE
Chemed annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Chemed EBITDA for the quarter ending September 30, 2024 was $0.108B, a 5.5% increase year-over-year.
- Chemed EBITDA for the twelve months ending September 30, 2024 was $0.427B, a 15.11% increase year-over-year.
- Chemed 2023 annual EBITDA was $0.402B, a 0.25% decline from 2022.
- Chemed 2022 annual EBITDA was $0.403B, a 0.15% increase from 2021.
- Chemed 2021 annual EBITDA was $0.402B, a 9.89% decline from 2020.
Chemed Annual EBITDA (Millions of US $) |
2023 |
$402 |
2022 |
$403 |
2021 |
$402 |
2020 |
$447 |
2019 |
$303 |
2018 |
$283 |
2017 |
$150 |
2016 |
$216 |
2015 |
$221 |
2014 |
$206 |
2013 |
$176 |
2012 |
$196 |
2011 |
$192 |
2010 |
$180 |
2009 |
$161 |
Chemed Quarterly EBITDA (Millions of US $) |
2024-09-30 |
$108 |
2024-06-30 |
$104 |
2024-03-31 |
$88 |
2023-12-31 |
$127 |
2023-09-30 |
$102 |
2023-06-30 |
$85 |
2023-03-31 |
$88 |
2022-12-31 |
$96 |
2022-09-30 |
$96 |
2022-06-30 |
$107 |
2022-03-31 |
$104 |
2021-12-31 |
$112 |
2021-09-30 |
$107 |
2021-06-30 |
$88 |
2021-03-31 |
$95 |
2020-12-31 |
$158 |
2020-09-30 |
$89 |
2020-06-30 |
$107 |
2020-03-31 |
$93 |
2019-12-31 |
$92 |
2019-09-30 |
$76 |
2019-06-30 |
$76 |
2019-03-31 |
$60 |
2018-12-31 |
$78 |
2018-09-30 |
$71 |
2018-06-30 |
$68 |
2018-03-31 |
$66 |
2017-12-31 |
$66 |
2017-09-30 |
$63 |
2017-06-30 |
$-30 |
2017-03-31 |
$51 |
2016-12-31 |
$62 |
2016-09-30 |
$52 |
2016-06-30 |
$48 |
2016-03-31 |
$54 |
2015-12-31 |
$59 |
2015-09-30 |
$59 |
2015-06-30 |
$53 |
2015-03-31 |
$49 |
2014-12-31 |
$59 |
2014-09-30 |
$49 |
2014-06-30 |
$51 |
2014-03-31 |
$47 |
2013-12-31 |
$50 |
2013-09-30 |
$40 |
2013-06-30 |
$36 |
2013-03-31 |
$50 |
2012-12-31 |
$56 |
2012-09-30 |
$47 |
2012-06-30 |
$49 |
2012-03-31 |
$44 |
2011-12-31 |
$56 |
2011-09-30 |
$51 |
2011-06-30 |
$45 |
2011-03-31 |
$40 |
2010-12-31 |
$48 |
2010-09-30 |
$46 |
2010-06-30 |
$43 |
2010-03-31 |
$43 |
2009-12-31 |
$40 |
2009-09-30 |
$41 |
2009-06-30 |
$37 |
2009-03-31 |
$43 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Outpatient & Home Care |
$8.238B |
$2.264B |
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
|